LDP

Dược Lâm Đồng (Ladophar) ·HNX ·2026Q1

▲▲ Improving positively

Operating efficiency is improving Net margin 11.25%, +7.97pp YoY
Price
8,100
Latest close
02 Jun 2026
P/E 5.17x
P/B 0.79x
EPS 1,566
BVPS 10,275
ROE 18.7%
ROA 10.5%
Profit Margin 11.2%
Asset Turnover 0.94x
Equity Mult. 1.77x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, LDP has not accelerated revenue sharply, but profitability is improving visibly — earnings have been recovering gradually over multiple periods. However, a significant portion of profit is supported by non-core sources, making the picture not entirely clear.

TTM REVENUE
VND 243bn
+4.0%YoY
NET MARGIN
11.25%
+8.0ppYoY
TTM NET PROFIT
VND 27bn
+257.3%YoY
Non-core income / PBT
55.9%
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 59.9 73.8 59.2 50.0 60.9 71.8 53.1 47.7 45.3 45.3 52.4 45.4
Growth -19% +25% +18% -18% -15% +35% +11% +5% -0% -14% +15%
Net Income 0.9 21.4 3.7 1.2 1.0 3.0 2.0 1.6 0.2 -9.9 -1.0 -2.9
Net Margin 1.56% 29.02% 6.32% 2.45% 1.67% 4.21% 3.70% 3.45% 0.39% -21.76% -1.90% -6.32%

Drivers of LDP's profit

TTM

Net profit attributable to parent increased vs last year, mainly helped by better other profit. Supporting and offsetting drivers:

Other profit ↑ 15.2bn
Gross profit ↑ 9.4bn
Finance costs ↓ 3.1bn
Selling expenses ↑ 6.3bn
TTM

Net profit attributable to parent declined vs prior quarter, mainly due to higher administrative expenses. Supporting and offsetting drivers:

Gross profit ↑ 1.2bn
Finance costs ↓ 0.6bn
Other profit ↑ 0.3bn
Administrative expenses ↑ 0.9bn
Selling expenses ↑ 0.5bn
Financial income ↓ 0.2bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 7.9% = 3.3% × 1.17 × 2.08
2026Q1 18.7% = 11.2% × 0.94 × 1.77

ROE rose from 7.9% to 18.7% — mainly driven by net margin, despite asset turnover and leverage moving in the opposite direction.

Net margin: 11.2% +8.0pp Asset turnover: 0.94x -0.23x Leverage: 1.77x -0.31x

Is the profit sustainable?

Margins improved (+8.0pp), but earnings still rely significantly on non-core sources — warrants closer scrutiny.

very positive positive stable watch under pressure

What is driving the margin?

Net margin expanded to 11.25%, rising 8.0pp. Core operating signals are improving as Gross margin rose 2.7pp are enough to offset pressure from SG&A / Revenue rose 2.2pp (with additional support from Other profit / Revenue rose 6.3pp and Net financial result / Revenue rose 1.5pp).

Most of the margin increase comes from non-core items — core operations have not kept pace, this is a margin expansion to watch carefully.

Profitability trend

Net Margin 11.25% +8.0pp
Gross Margin 33.93% +2.7pp
SG&A / Revenue 27.36% +2.2pp
Non-core / Revenue 4.90% +7.7pp

TTM YoY · 2025Q1 -> 2026Q1

Watchpoints

Other income is supporting margin

Other income accounts for 55.9% of PBT and lifted net margin by 7.7pp — separate the operating contribution from this source.

Is capital being used efficiently?

Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.

Is capital being deployed efficiently?

Track how much operating profit the business generates on invested capital.

Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC
NOPAT Margin
Capital Turnover 1.27x −0.35x
Average Invested Capital 191.1bn +46.6bn

Balance Sheet

ROIC above should be read with industry context — the balance sheet below adds perspective. Capital structure is conservative with low leverage — liabilities at 0.61x equity, net debt at 0.22x equity.

Inventory ended the period at 55.4bn, roughly 18.0% of total assets.

Over the last 12 months, working capital absorbed 27.6bn of cash, mainly because of higher receivables and higher inventories.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables increased → lower CFO: −16.3bn
Inventories increased → lower CFO: −8.6bn
Payables decreased → lower CFO: −2.7bn

Working Capital Efficiency

Cash conversion cycle lengthened by 38.6 days versus the same period last year. The main moves came from DIO rose 25.9 days, DSO rose 20.8 days, and DPO rose 8.1 days.

Working capital cycle lengthened mainly due to slower inventory turnover — more capital is being tied up in inventory.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 131.4 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +20.8 days, pointing to slower receivables turnover.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 72.5 days +20.8 days
Inventory 117.1 days +25.9 days
Payables 58.2 days +8.1 days
Cash Conversion Cycle 131.4 days +38.6 days

Is financial risk significant?

Leverage is safe but FCF is negative at 62.9bn due to capex of 63.9bn — an investment choice, not an urgent risk.

Leverage & Liquidity

Leverage is balanced for now, with net debt / equity at 0.22x and interest coverage at 2.74x.

At present, short-term debt accounts for 100.0% of total debt, cash equals 31.7% of debt, and total debt stands at 61.1bn.

Watchpoints

Short-term refinancing pressure is meaningful

Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.

Leverage and liquidity trend

Net Debt / Equity 0.22x −0.26x
Interest Coverage 2.74x +1.78x
Cash / Debt 31.7% +6.4pp
Short-term Debt / Total Debt 100.0% 0.0pp
CFO / NI 0.04x −1.09x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 3.5bn in 2025, against investing cash flow of -62.7bn.

Post-investment cash flow was negative +59.2bn. Financing cash flow was positive +66.4bn.

CFO / net income was 0.04x.

After spending +63.9bn on fixed-asset investment, the business generated trailing free cash flow of −62.9bn.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 1.0bn −7.6bn
Cash Capex 63.9bn +61.4bn
FCF TTM −62.9bn −69.0bn

Investment Takeaway

The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is operating efficiency, with net margin improving 8.0 pp. The next item to monitor is the earnings mix, when non-core contribution is -13.2%. The main risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 131 days.

Improvement: operating efficiency is getting better, with trailing-12M net margin at 11.25% after expanding 8.0pp versus the same period last year.

Watchpoint: the earnings mix still needs monitoring, with net financial result still accounting for -13.2% of PBT and CFO / net income currently at 0.04x.

Key risk: working capital remains tied up for too long, with cash cycle at 131.4 days.

Statement Data

Item 2025 2024 2023 2022 2021
Net Revenue
243.9 218.0 186.0 187.4 161.9
Cost of Goods Sold
162.7 153.6 148.8 149.9 0.0
Gross Profit
81.2 64.4 37.2 37.5 21.0
Financial Expenses
5.1 7.0 7.7 16.4 -3.2
Selling Expenses
39.6 30.9 29.9 39.7 -30.5
General and Administrative Expenses
24.2 20.2 19.6 23.1 -10.8
Operating Profit
13.4 6.6 -19.2 -38.9 8.0
Profit Before Tax
28.7 6.9 -20.1 -38.9 42.4
Net Income
28.6 6.9 -20.1 -38.9 39.1
Profit Attributable to Parent
28.6 6.9 -20.1 -38.9 39.1
Earnings per Share
2,030.00 545.00 -1,583.00 -3,063.00 3,074.00

Explore Other Stocks In The Same Sector

DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.